Development of Novel Fluorinated Polyphenols as Selective Inhibitors of DYRK1A/B Kinase for Treatment of Neuroinflammatory Diseases including Parkinson’s Disease
Open Access
- 15 March 2023
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (3) , 443
Abstract
Natural polyphenol derivatives such as those found in green tea have been known for a long time for their useful therapeutic activity. Starting from EGCG, we have discovered a new fluorinated polyphenol derivative (1c) characterized by improved inhibitory activity against DYRK1A/B enzymes and by considerably improved bioavailability and selectivity. DYRK1A is an enzyme that has been implicated as an important drug target in various therapeutic areas, including neurological disorders (Down syndrome and Alzheimer’s disease), oncology, and type 2 diabetes (pancreatic β-cell expansion). Systematic structure–activity relationship (SAR) on trans-GCG led to the discovery that the introduction of a fluoro atom in the D ring and methylation of the hydroxy group from para to the fluoro atom provide a molecule (1c) with more desirable drug-like properties. Owing to its good ADMET properties, compound 1c showed excellent activity in two in vivo models, namely the lipopolysaccharide (LPS)-induced inflammation model and the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) animal model for Parkinson’s disease.Keywords
Funding Information
- National Institute of Aging (1R43AG063560-01)
- New York State Office for People with Developmental Disabilities (1R43AG063560-01)
This publication has 47 references indexed in Scilit:
- Assessment of plasma concentrations of (−)-epigallocatechin gallate in mice following administration of a dose reflecting consumption of a standard green tea beverageFood Chemistry, 2011
- The down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4Neuroscience, 2008
- Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generationJournal of Neuroinflammation, 2008
- EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomersNature Structural & Molecular Biology, 2008
- Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndromeThe FASEB Journal, 2008
- In vitro and in vivo anti-allergic effects of ‘benifuuki’ green tea containing O-methylated catechin and ginger extract enhancementCytotechnology, 2007
- Dual‐specificity tyrosine(Y)‐phosphorylation regulated kinase 1A‐mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer’s diseaseJournal of Neurochemistry, 2007
- Kinetic Properties of a MNB/DYRK1A Mutant Suitable for the Elucidation of Biochemical PathwaysBiochemistry, 2006
- Proteomic Characterization of Postmortem Amyloid Plaques Isolated by Laser Capture MicrodissectionJournal of Biological Chemistry, 2004
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984